Cutaneous malignant melanoma associated with papillary thyroid cancer
- PMID: 20711283
- PMCID: PMC2917700
- DOI: 10.5021/ad.2010.22.3.370
Cutaneous malignant melanoma associated with papillary thyroid cancer
Abstract
As the survival from cutaneous malignant melanoma and its clinical concerns have been steadily increasing, the possibility has been raised of an increased risk of second primary cancers in the patients with malignant melanoma. Especially, recent studies have identified an association between cutaneous malignant melanoma and thyroid carcinoma. We here report on a case of cutaneous malignant melanoma that developed in a 61-year-old female patient who had hypothyroidism caused by papillary thyroid carcinoma. We suggest that the individuals who have cutaneous malignant melanoma may be predisposed to other primary cancers and especially thyroid carcinoma. Continuous monitoring of the thyroid function in melanoma patients is required because hypothyroidism can worsen due to malignant melanoma and this is probably associated with thyroid carcinoma.
Keywords: Hypothyroidism; Melanoma; Papillary thyroid carcinoma.
Figures



References
-
- Fraser DG, Bull JG, Jr, Dunphy JE. Malignant melanoma and coexisting malignant neoplasms. Am J Surg. 1971;122:169–174. - PubMed
-
- Shah M, Orengo IF, Rosen T. High prevalence of hypothyroidism in male patients with cutaneous melanoma. Dermatol Online J. 2006;12:1. - PubMed
-
- Goggins W, Daniels GH, Tsao H. Elevation of thyroid cancer risk among cutaneous melanoma survivors. Int J Cancer. 2006;118:185–188. - PubMed
-
- Kang SK, Jang AK, Choi JH, Sung KJ, Moon KC, Koh JK. Second primary cancers in patients with cutaneous malignant melanoma. Korean J Dermatol. 2001;39:798–802.
-
- Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM, Diwan AH. Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer. 2006;13:1269–1277. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials